Logo image of MCRI

MONARCH CASINO & RESORT INC (MCRI) Stock Fundamental Analysis

USA - NASDAQ:MCRI - US6090271072 - Common Stock

101.7 USD
-2.4 (-2.31%)
Last: 9/15/2025, 5:20:01 PM
101.7 USD
0 (0%)
After Hours: 9/15/2025, 5:20:01 PM
Fundamental Rating

6

Taking everything into account, MCRI scores 6 out of 10 in our fundamental rating. MCRI was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. MCRI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MCRI is not valued too expensively and it also shows a decent growth rate. With these ratings, MCRI could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MCRI was profitable.
MCRI had a positive operating cash flow in the past year.
In the past 5 years MCRI has always been profitable.
Each year in the past 5 years MCRI had a positive operating cash flow.
MCRI Yearly Net Income VS EBIT VS OCF VS FCFMCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

MCRI has a better Return On Assets (11.15%) than 87.22% of its industry peers.
MCRI has a better Return On Equity (14.59%) than 72.93% of its industry peers.
MCRI's Return On Invested Capital of 17.60% is amongst the best of the industry. MCRI outperforms 87.97% of its industry peers.
MCRI had an Average Return On Invested Capital over the past 3 years of 16.41%. This is in line with the industry average of 15.68%.
The 3 year average ROIC (16.41%) for MCRI is below the current ROIC(17.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROIC 17.6%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
MCRI Yearly ROA, ROE, ROICMCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MCRI has a better Profit Margin (14.72%) than 87.22% of its industry peers.
In the last couple of years the Profit Margin of MCRI has grown nicely.
MCRI has a better Operating Margin (24.09%) than 87.97% of its industry peers.
In the last couple of years the Operating Margin of MCRI has grown nicely.
With a decent Gross Margin value of 54.43%, MCRI is doing good in the industry, outperforming 63.91% of the companies in the same industry.
MCRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
MCRI Yearly Profit, Operating, Gross MarginsMCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MCRI is creating value.
The number of shares outstanding for MCRI has been reduced compared to 1 year ago.
Compared to 5 years ago, MCRI has more shares outstanding
MCRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MCRI Yearly Shares OutstandingMCRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCRI Yearly Total Debt VS Total AssetsMCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 9.25 indicates that MCRI is not in any danger for bankruptcy at the moment.
MCRI has a better Altman-Z score (9.25) than 95.49% of its industry peers.
MCRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.25
ROIC/WACC1.97
WACC8.93%
MCRI Yearly LT Debt VS Equity VS FCFMCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MCRI has a Current Ratio of 0.73. This is a bad value and indicates that MCRI is not financially healthy enough and could expect problems in meeting its short term obligations.
MCRI has a worse Current ratio (0.73) than 60.90% of its industry peers.
A Quick Ratio of 0.67 indicates that MCRI may have some problems paying its short term obligations.
With a Quick ratio value of 0.67, MCRI is not doing good in the industry: 60.90% of the companies in the same industry are doing better.
MCRI does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.67
MCRI Yearly Current Assets VS Current LiabilitesMCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.30% over the past year.
Measured over the past years, MCRI shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.69% on average per year.
The Revenue has been growing slightly by 4.64% in the past year.
Measured over the past years, MCRI shows a quite strong growth in Revenue. The Revenue has been growing by 15.95% on average per year.
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%

3.2 Future

Based on estimates for the next years, MCRI will show a small growth in Earnings Per Share. The EPS will grow by 5.77% on average per year.
MCRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y12.11%
EPS Next 2Y8.94%
EPS Next 3Y5.77%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MCRI Yearly Revenue VS EstimatesMCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
MCRI Yearly EPS VS EstimatesMCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 19.12, the valuation of MCRI can be described as rather expensive.
68.42% of the companies in the same industry are more expensive than MCRI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.27, MCRI is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.31, MCRI is valued on the expensive side.
MCRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 67.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.77. MCRI is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.12
Fwd PE 17.31
MCRI Price Earnings VS Forward Price EarningsMCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

MCRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 68.42% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MCRI indicates a somewhat cheap valuation: MCRI is cheaper than 78.95% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.81
EV/EBITDA 10.05
MCRI Per share dataMCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

MCRI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of MCRI may justify a higher PE ratio.
PEG (NY)1.58
PEG (5Y)0.81
EPS Next 2Y8.94%
EPS Next 3Y5.77%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.15%, MCRI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.93, MCRI pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, MCRI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.15%

5.2 History

MCRI has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MCRI Yearly Dividends per shareMCRI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

MCRI pays out 28.06% of its income as dividend. This is a sustainable payout ratio.
DP28.06%
EPS Next 2Y8.94%
EPS Next 3Y5.77%
MCRI Yearly Income VS Free CF VS DividendMCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MCRI Dividend Payout.MCRI Dividend Payout, showing the Payout Ratio.MCRI Dividend Payout.PayoutRetained Earnings

MONARCH CASINO & RESORT INC

NASDAQ:MCRI (9/15/2025, 5:20:01 PM)

After market: 101.7 0 (0%)

101.7

-2.4 (-2.31%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-16 2025-07-16/amc
Earnings (Next)10-21 2025-10-21/amc
Inst Owners67.92%
Inst Owner Change-2.07%
Ins Owners23.21%
Ins Owner Change1%
Market Cap1.86B
Analysts74.55
Price Target102.2 (0.49%)
Short Float %2.53%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield 1.15%
Yearly Dividend1.19
Dividend Growth(5Y)N/A
DP28.06%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)4.02%
Max EPS beat(2)18.74%
EPS beat(4)4
Avg EPS beat(4)12.26%
Min EPS beat(4)4.02%
Max EPS beat(4)20.88%
EPS beat(8)5
Avg EPS beat(8)2.67%
EPS beat(12)6
Avg EPS beat(12)1.12%
EPS beat(16)9
Avg EPS beat(16)1.98%
Revenue beat(2)2
Avg Revenue beat(2)1.81%
Min Revenue beat(2)0.23%
Max Revenue beat(2)3.39%
Revenue beat(4)4
Avg Revenue beat(4)1.67%
Min Revenue beat(4)0.23%
Max Revenue beat(4)3.39%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)1.62%
PT rev (1m)0.8%
PT rev (3m)13.86%
EPS NQ rev (1m)1.53%
EPS NQ rev (3m)5.24%
EPS NY rev (1m)7.72%
EPS NY rev (3m)7.72%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)2.41%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 19.12
Fwd PE 17.31
P/S 3.47
P/FCF 17.81
P/OCF 12.49
P/B 3.45
P/tB 3.63
EV/EBITDA 10.05
EPS(TTM)5.32
EY5.23%
EPS(NY)5.87
Fwd EY5.78%
FCF(TTM)5.71
FCFY5.61%
OCF(TTM)8.14
OCFY8%
SpS29.27
BVpS29.52
TBVpS28.04
PEG (NY)1.58
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROCE 22.75%
ROIC 17.6%
ROICexc 20.14%
ROICexgc 21.3%
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
FCFM 19.51%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
ROICexc(3y)17.94%
ROICexc(5y)14.16%
ROICexgc(3y)18.89%
ROICexgc(5y)14.91%
ROCE(3y)21.22%
ROCE(5y)16.86%
ROICexcg growth 3Y10.75%
ROICexcg growth 5Y23.79%
ROICexc growth 3Y10.64%
ROICexc growth 5Y23.89%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 83.34%
Cap/Sales 8.3%
Interest Coverage 156.5
Cash Conversion 81.68%
Profit Quality 132.59%
Current Ratio 0.73
Quick Ratio 0.67
Altman-Z 9.25
F-Score7
WACC8.93%
ROIC/WACC1.97
Cap/Depr(3y)95.66%
Cap/Depr(5y)184.37%
Cap/Sales(3y)9.04%
Cap/Sales(5y)17.42%
Profit Quality(3y)131.09%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
EPS Next Y12.11%
EPS Next 2Y8.94%
EPS Next 3Y5.77%
EPS Next 5YN/A
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
EBIT growth 1Y9.89%
EBIT growth 3Y8.5%
EBIT growth 5Y24.7%
EBIT Next Year68.87%
EBIT Next 3Y20.48%
EBIT Next 5YN/A
FCF growth 1Y-20.42%
FCF growth 3Y4.73%
FCF growth 5YN/A
OCF growth 1Y-11.01%
OCF growth 3Y3.18%
OCF growth 5Y17.36%